Augmentin is FDA-approved to treat urinary tract infections, but it is not the best choice for most cases. A major meta-analysis published by the American Academy of Family Physicians found that Augmentin is significantly less effective than the other antibiotics commonly used for lower UTIs, including trimethoprim-sulfamethoxazole (Bactrim) and nitrofurantoin (Macrobid). So while it can work, there are typically better options available.
Why Augmentin Is Not a First Choice for UTIs
Augmentin combines two ingredients: amoxicillin, which kills bacteria by stopping their growth, and clavulanic acid, which prevents bacteria from disabling the amoxicillin. That combination makes it useful for infections where bacteria have developed resistance to plain amoxicillin, like certain sinus and skin infections. For UTIs, though, the picture is less favorable.
The antibiotics most commonly prescribed for uncomplicated bladder infections, such as nitrofurantoin and trimethoprim-sulfamethoxazole, perform similarly to each other in clinical trials. Augmentin is the outlier. When researchers compared all the common UTI antibiotics head to head, Augmentin consistently came up short on both short-term and long-term cure rates. This is a big reason most clinical guidelines don’t list it as a first-line UTI treatment.
Resistance is part of the problem. In a large study of E. coli isolates (E. coli causes the vast majority of UTIs), about 35% were resistant to amoxicillin-clavulanate. That means roughly one in three UTI-causing bacteria may not respond to Augmentin at all.
When Augmentin Might Still Be Prescribed
Augmentin’s FDA approval for UTIs is specifically for infections caused by bacteria that produce an enzyme called beta-lactamase, which normally breaks down penicillin-type antibiotics. The bacteria covered include E. coli, Klebsiella, and Enterobacter species. If a urine culture shows your infection is caused by one of these organisms and the lab confirms it’s susceptible to amoxicillin-clavulanate, Augmentin can be a reasonable option.
It also comes up in situations where first-line antibiotics aren’t suitable. If you’re allergic to sulfa drugs (ruling out Bactrim) or can’t tolerate nitrofurantoin, or if your urine culture shows the bacteria are resistant to first-line options, Augmentin may be a practical backup. Some research suggests it may also serve as a step-down oral antibiotic for complicated UTIs or kidney infections after initial treatment with intravenous antibiotics, though the evidence here is limited.
Effectiveness by the Numbers
Clinical trial data from Augmentin’s prescribing information gives a useful snapshot of how well it clears bacteria in complicated UTIs and kidney infections. In a trial of over 600 patients, the bacteriologic success rates were:
- 2 to 4 days after treatment: about 80% to 81%
- 5 to 9 days after treatment: 52% to 58%
- 2 to 4 weeks after treatment: 52% to 55%
Those numbers tell an important story. While Augmentin initially clears the infection in roughly 4 out of 5 patients, nearly half see the bacteria return within a few weeks. That high relapse rate is a significant drawback compared to antibiotics with more sustained cure rates for UTIs.
Side Effects to Expect
The clavulanic acid in Augmentin is notoriously tough on the digestive system. Diarrhea is the most common complaint, and it tends to be more frequent with Augmentin than with many other UTI antibiotics. Nausea, vomiting, and stomach cramps are also common. Taking the medication with food can help reduce stomach upset, but GI symptoms remain a trade-off that makes Augmentin less appealing when equally effective (or more effective) alternatives exist with milder side effect profiles.
Yeast infections are another concern, particularly for people prone to them. Like all antibiotics, Augmentin disrupts the balance of normal bacteria in the body, but its broad-spectrum activity means it tends to be more disruptive than narrower antibiotics like nitrofurantoin.
Augmentin for UTIs During Pregnancy
UTIs are common during pregnancy, and the antibiotic options narrow considerably because many drugs pose risks to the developing baby. Augmentin is generally considered acceptable in pregnancy. Most studies have not found an increased chance of birth defects when it’s taken during the first trimester, and it does not appear to raise the risk of preterm delivery or low birth weight. A long-term study that followed children up to age 11 found no learning or behavior problems linked to prenatal exposure.
One specific caution applies: in cases of preterm premature rupture of membranes (when the water breaks too early), some studies have linked amoxicillin-clavulanate to a slightly higher risk of a serious intestinal condition in the newborn called necrotizing enterocolitis. For that reason, other antibiotics are typically preferred in that particular scenario.
Better Alternatives for Most UTIs
For a straightforward bladder infection, the antibiotics with the strongest evidence and guideline support are nitrofurantoin (typically a 5-day course) and trimethoprim-sulfamethoxazole (usually 3 days). Both have higher cure rates for uncomplicated UTIs, narrower activity that’s less likely to disrupt your gut bacteria, and lower resistance rates for the organisms that cause most bladder infections.
If you’ve been prescribed Augmentin for a UTI, it likely means your provider had a specific reason: your culture results pointed to it, you have allergies limiting other choices, or your infection is complicated. It’s worth asking whether a urine culture was done, since the gap between Augmentin’s effectiveness and that of first-line drugs is large enough that choosing the right antibiotic based on lab results matters more than usual.